Yahoo Web Search

Search results

    • GSK shares fall 9% in wake of Zantac court ruling

      GSK shares fall 9% in wake of Zantac court ruling

      Pharmaceutical Technology via Yahoo Finance· 3 hours ago

      It also highlighted that following 16 epidemiological studies looking at...and that the companies had properly marketed Zantac without its alleged cancer...